Combination of direct rennin inhibitor - aliskiren, angiotensin II receptor blocker - valsartan, and calcium channel blocker - amlodipine, in therapy of hypertensive patient with gout (case report)

被引：0

作者：

Dralova, O. V. ^{[1
]}

Maksimov, M. L. ^{[1
]}

机构：

[1] IM Setchenov First Moscow State Med Univ, Trubetskaya Ul 8-2, Moscow 119991, Russia

来源：

RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2011年 / 7卷 / 04期

关键词：

arterial hypertension; gout; valsartan; amlodipine; aliskiren;

D O I：

10.20996/1819-6446-2011-7-4-468-472

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pharmacotherapy optimization in patients with arterial hypertension and gout is very important. Achievement of the target blood pressure levels is possible with the use of combinations of effective antihypertensive drugs with neutral metabolic profile and safety, in particular a combination of valsartan, amlodipine and aliskiren. Clinical case of this combination use in patient with arterial hypertension and gout is presented.

引用

页码：468 / 472

页数：5

共 14 条

[11] Cardiovascular drugs and serum uric acid [J].

Reyes, AJ .

CARDIOVASCULAR DRUGS AND THERAPY, 2003, 17 (5-6) :397-414

[12] Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism [J].

Takahashi, S ;

Moriwaki, Y ;

Yamamoto, T ;

Tsutsumi, Z ;

Ka, T ;

Fukuchi, M .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (06) :572-575

[13]

Taylor W., 2002, CLIN MED, V80, P77

[14] Metabolic syndrome and ischemic heart disease in gout [J].

Vázquez-Mellado, JV ;

García, CG ;

Vásquez, SG ;

Medrano, G ;

Ornelas, M ;

Alcocer, L ;

Marquez, A ;

Burgos-Vargas, RN .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2004, 10 (03) :105-109

← 1 2 →